Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line

J Dermatol Sci. 2009 Apr;54(1):52-4. doi: 10.1016/j.jdermsci.2008.10.006. Epub 2008 Dec 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation Factors / drug effects
  • Blood Coagulation Factors / metabolism
  • Carcinoma, Basal Cell / metabolism*
  • Carcinoma, Basal Cell / pathology
  • Cell Line, Tumor
  • Gene Expression / drug effects
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Patched Receptors
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • RNA-Binding Proteins
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / metabolism
  • Receptors, G-Protein-Coupled / drug effects
  • Receptors, G-Protein-Coupled / metabolism
  • Ribosomal Proteins
  • Smoothened Receptor
  • Tacrolimus / pharmacology*
  • Transcription Factors / antagonists & inhibitors*
  • Transcription Factors / metabolism
  • Zinc Finger Protein GLI1

Substances

  • Blood Coagulation Factors
  • GLI1 protein, human
  • Immunosuppressive Agents
  • Patched Receptors
  • Proto-Oncogene Proteins c-bcl-2
  • RNA-Binding Proteins
  • RPL29 protein, human
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Ribosomal Proteins
  • SMO protein, human
  • Smoothened Receptor
  • Transcription Factors
  • Zinc Finger Protein GLI1
  • Tacrolimus